Workflow
Tenet Health(THC) - 2024 Q4 - Annual Report

Hospital Operations - As of December 31, 2024, the Hospital Operations segment included 49 acute care and specialty hospitals, 135 outpatient facilities, and a joint venture in revenue cycle management with Conifer Health Solutions, LLC[12] - In 2024, the company opened a new 92-bed hospital in San Antonio and acquired a majority interest in a 36-bed rehabilitation hospital in El Paso[13] - The company sold six hospitals in California and three in South Carolina in 2024 to refine its portfolio and improve profitability[14] - The total number of licensed beds across all hospitals was 12,435 as of December 31, 2024[19] - Approximately 72% of the outpatient centers were located in Arizona and Texas, which may enhance operational efficiencies but also increase risk exposure[22] - The company owned over 650 physician practices and was affiliated with nearly 1,135 physicians as of December 31, 2024[34] - The Ambulatory Care segment held ownership interests in 518 ambulatory surgery centers and 25 surgical hospitals across 37 states as of December 31, 2024[26] - The company is focusing on expanding its ambulatory care business and improving accessibility at outpatient centers to address competitive challenges[56] Workforce and Labor Challenges - The company faced challenges in recruiting and retaining physicians due to a shortage in certain high-demand specialties[35] - Approximately 32% of the company's employees are nurses, with 21% of employees in the Hospital Operations segment represented by labor unions[36][45] - The company is experiencing shortages of advanced practice providers and critical-care nurses, leading to increased labor costs and reliance on higher-cost contract labor[42][44] - The company has made significant investments in education and training for newly licensed medical support personnel to streamline onboarding and reduce training expenses[44] - The company is actively engaging in community healthcare programs to increase access to healthcare careers and improve workforce recruitment[44] Financial Performance - Net operating revenues for 2024 reached $20,665 million, a 0.57% increase from $20,548 million in 2023[451] - Operating income significantly improved to $5,956 million in 2024, compared to $2,510 million in 2023, marking a 137.5% increase[451] - Net income available to Tenet Healthcare Corporation common shareholders surged to $3,200 million in 2024, up from $611 million in 2023, representing a 423.5% increase[451] - Basic earnings per share rose to $33.02 in 2024, compared to $6.01 in 2023, reflecting a 450.8% increase[451] - Total comprehensive net income for 2024 was $4,065 million, compared to $1,311 million in 2023, indicating a 210.5% increase[454] - The company reported a decrease in salaries, wages, and benefits to $8,801 million in 2024 from $9,146 million in 2023, a reduction of 3.8%[451] - Interest expense decreased to $826 million in 2024 from $901 million in 2023, a decline of 8.3%[451] - Net income for the year ended December 31, 2024, was $4,064 million, a significant increase from $1,311 million in 2023 and $1,001 million in 2022, reflecting a year-over-year growth of 210%[460] Regulatory and Compliance Issues - The company is subject to extensive government regulations, which may require adjustments to facilities and services to ensure compliance[59][60] - Compliance with HIPAA regulations is mandatory, with potential civil penalties for violations, which could increase liability risks[76] - The company operates under various federal and state antitrust laws, with heightened scrutiny from the FTC on healthcare transactions that may affect local patient service options[84] - The healthcare industry is subject to civil and criminal enforcement efforts, which could lead to penalties and affect the company's operations[70] - The company regularly enters into financial arrangements with physicians, ensuring compliance with anti-kickback and fraud laws[68] Investments and Capital Management - The company expects to complete construction of a new medical campus in Port St. Lucie, including a 54-bed surgical hospital, by late 2025[13] - Total assets increased to $28,936 million as of December 31, 2024, compared to $28,312 million in 2023, reflecting a growth of 2.2%[449] - Cash and cash equivalents rose significantly to $3,019 million in 2024, up from $1,228 million in 2023, marking an increase of 145.5%[449] - Shareholders' equity increased to $4,171 million in 2024, compared to $1,608 million in 2023, representing a growth of 159.5%[449] - The company has reserves for incurred but not reported claims, based on modeled estimates of losses and related expenses[98] Revenue Streams and Patient Care - The company reported net patient service revenues primarily from Medicare, Medicaid, managed care, and uninsured patients, reflecting the diverse revenue streams in its operations[472] - The company recognized grant income of $10 million in 2024, down from $16 million in 2023 and $194 million in 2022, showing a declining trend in grant income[468] - Total estimated costs for caring for uninsured and charity patients amounted to $617 million in 2024, compared to $609 million in 2023[525] - Revenue recognized from revenue cycle management services totaled $58 million in 2024, down from $71 million in 2023[527] Share Repurchase and Equity Management - The 2022 share repurchase program authorized up to $1.000 billion, with 5.889 million shares repurchased at an average price of $42.45[516] - The 2024 share repurchase program authorized up to $1.500 billion with no expiration date, allowing for flexible repurchases based on market conditions[518][519] - Total number of shares purchased under the 2024 share repurchase program reached 795,000 shares at an average price of $155.95 per share, with a remaining maximum dollar value of $1,376 million available for repurchase[520]